Atlas Trials

ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer

Clinical trial NCT07318389 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07318389
Sponsor
M.D. Anderson Cancer Center
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Dynamic Tumor ResistanceMetastatic Colorectal Cancer
Start date
2026-06-10
Primary completion
2027-11-14
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.